Medtronic plc (MDT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-24. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Quarterly

0 3.5B 7B 10.5B Q1 '22: 8B Q2 '22: 7.8B Q3 '22: 7.8B Q4 '22: 8.1B Q1 '23: 7.4B Q2 '23: 7.6B Q3 '23: 7.7B Q4 '23: 8.5B Q1 '24: 7.7B Q2 '24: 8B Q3 '24: 8.1B Q4 '24: 8.6B Q1 '25: 7.9B Q2 '25: 8.4B Q3 '25: 8.3B Q4 '25: 8.9B Q1 '26: 8.6B Q2 '26: 9B Q3 '26: 9B Q4 '26: 9.8B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Gross Profit Quarterly

0 2B 4B 6B Q1 '16: 4.8B Q2 '16: 4.9B Q3 '16: 4.8B Q4 '16: 5.2B Q1 '17: 4.9B Q2 '17: 5B Q3 '17: 5B Q4 '17: 5.5B Q1 '18: 5B Q2 '18: 4.9B Q3 '18: 5.2B Q4 '18: 5.7B Q1 '19: 5.2B Q2 '19: 5.3B Q3 '19: 5.3B Q4 '19: 5.7B Q1 '20: 5.1B Q2 '20: 5.3B Q3 '20: 5.3B Q4 '20: 3.7B Q2 '16 Q1 '17 Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q4 '20

Operating Income Quarterly

0 700M 1.4B 2.1B Q1 '22: 859M Q2 '22: 1.6B Q3 '22: 1.7B Q4 '22: 1.7B Q1 '23: 1.1B Q2 '23: 1.4B Q3 '23: 1.4B Q4 '23: 1.6B Q1 '24: 1.3B Q2 '24: 1.3B Q3 '24: 1.5B Q4 '24: 1.1B Q1 '25: 1.3B Q2 '25: 1.6B Q3 '25: 1.6B Q4 '25: 1.4B Q1 '26: 1.4B Q2 '26: 1.7B Q3 '26: 1.5B Q4 '26: 1.9B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Net Income Quarterly

0 600M 1.2B 1.8B Q1 '22: 763M Q2 '22: 1.3B Q3 '22: 1.5B Q4 '22: 1.5B Q1 '23: 929M Q2 '23: 427M Q3 '23: 1.2B Q4 '23: 1.2B Q1 '24: 791M Q2 '24: 909M Q3 '24: 1.3B Q4 '24: 654M Q1 '25: 1B Q2 '25: 1.3B Q3 '25: 1.3B Q4 '25: 1.1B Q1 '26: 1B Q2 '26: 1.4B Q3 '26: 1.1B Q4 '26: 1.2B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Cost of Revenue Quarterly

0 1.5B 3B 4.5B Q1 '22: 2.6B Q2 '22: 2.5B Q3 '22: 2.5B Q4 '22: 2.6B Q1 '23: 2.5B Q2 '23: 2.5B Q3 '23: 2.7B Q4 '23: 3B Q1 '24: 2.6B Q2 '24: 2.8B Q3 '24: 2.8B Q4 '24: 3B Q1 '25: 2.8B Q2 '25: 2.9B Q3 '25: 2.8B Q4 '25: 3.1B Q1 '26: 3B Q2 '26: 3.1B Q3 '26: 3.3B Q4 '26: 3.4B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Operating Cash Flow Quarterly

0 1B 2B 3B Q1 '22: 1.3B Q2 '22: 1.8B Q3 '22: 2.2B Q4 '22: 2.1B Q1 '23: 1.1B Q2 '23: 922M Q3 '23: 1.6B Q4 '23: 2.5B Q1 '24: 875M Q2 '24: 661M Q3 '24: 2.5B Q4 '24: 2.8B Q1 '25: 986M Q2 '25: 958M Q3 '25: 2.6B Q4 '25: 2.5B Q1 '26: 1.1B Q2 '26: 925M Q3 '26: 2.7B Q4 '26: 2.6B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Free Cash Flow Quarterly

0 800M 1.6B 2.4B Q1 '22: 914M Q2 '22: 1.5B Q3 '22: 1.9B Q4 '22: 1.7B Q1 '23: 657M Q2 '23: 599M Q3 '23: 1.2B Q4 '23: 2.1B Q1 '24: 521M Q2 '24: 200M Q3 '24: 2.1B Q4 '24: 2.4B Q1 '25: 466M Q2 '25: 554M Q3 '25: 2.1B Q4 '25: 2.1B Q1 '26: 584M Q2 '26: 457M Q3 '26: 2.3B Q4 '26: 2.1B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 500M 1B 1.5B Q2 '20: 1.4B Q3 '20: 1.4B Q1 '21: 1.4B Q2 '21: 1.4B Q3 '21: 1.4B Q1 '22: 1.4B Q2 '22: 1.4B Q3 '22: 1.4B Q1 '23: 1.3B Q2 '23: 1.3B Q3 '23: 1.3B Q1 '24: 1.3B Q2 '24: 1.3B Q3 '24: 1.3B Q1 '25: 1.3B Q2 '25: 1.3B Q3 '25: 1.3B Q1 '26: 1.3B Q2 '26: 1.3B Q3 '26: 1.3B Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q1 '22: 2.86 Q2 '22: 3.47 Q3 '22: 3.63 Q4 '22: 3.73 Q1 '23: 3.87 Q2 '23: 3.22 Q3 '23: 3.04 Q4 '23: 2.82 Q1 '24: 2.71 Q2 '24: 3.07 Q3 '24: 3.14 Q4 '24: 2.75 Q1 '25: 2.96 Q2 '25: 3.27 Q3 '25: 3.29 Q4 '25: 3.62 Q1 '26: 3.63 Q2 '26: 3.71 Q3 '26: 3.59 Q4 '26: 3.74 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.